Published on 02/12/2025

KPIs for AI Governance & Security

In recent years, the pharmaceutical industry has embraced the potential of artificial intelligence (AI) and machine learning (ML) technologies to enhance drug development and streamline clinical operations. However, with these advanced methodologies come a plethora of challenges, particularly concerning governance and security. Understanding the Key Performance Indicators (KPIs) for AI governance and security is crucial for ensuring compliance with regulatory standards and enhancing operational efficiencies. This article provides a step-by-step tutorial for pharmaceutical professionals focusing on AI/ML model validation in Good Automated Manufacturing Practice (GxP) analytics.

Step 1: Understanding Risks in AI/ML Model Validation

The first step in establishing a robust AI governance framework is identifying and understanding the risks associated with AI/ML model validation. In this context, risks can derive from various factors, including data integrity, model accuracy, unintended bias, and security concerns.

By understanding the concept of intended use risk, pharmaceutical professionals can better evaluate how AI/ML applications can affect patient safety and product quality. For example, the model’s intended use should align with regulatory expectations, particularly those outlined in 21 CFR Part 11, which deals with electronic records and signatures. This ensures that the model’s outputs meet established quality criteria and that the associated risks are thoroughly assessed.

An essential component of managing intended use risk involves conducting comprehensive data readiness curation. The data used to train and validate AI/ML models must be representative of the target population and free from biases that could skew the results. The data must also adhere to industry standards for quality, accuracy, and accessibility.

Step 2: Conducting Bias and Fairness Testing

Bias in AI/ML models can lead to incorrect predictions, jeopardizing patient safety and potentially leading to regulatory non-compliance. Therefore, establishing mechanisms for bias and fairness testing is critical. This process involves evaluating whether the model performs equally well across different demographic groups, minimizing detrimental impacts on vulnerable populations.

To begin bias and fairness testing, follow these steps:

• Data Segmentation: Divide your dataset into several demographic segments to assess how well the model performs across different criteria.
• Performance Metrics: Implement statistical measures such as equal opportunity, predictive parity, and overall accuracy to quantify model performance across these segments.
• Model Adjustment: If biases are detected, refine the model or the data. Techniques for mitigation may include reweighted datasets or model architectures designed to counteract detected biases.
• Re-evaluation: Conduct periodic reviews of the model’s fairness metrics to ensure continued compliance and performance across diverse populations.

Organizations should document the entire process as part of their governance framework, as thorough documentation is essential for any regulatory audits or inspections.

Step 3: Model Verification and Validation

Model verification and validation (V&V) are pivotal in ensuring that AI/ML models meet predefined specifications and requirements. This process should adhere to the guidelines set forth by GAMP 5, which provides a structured approach to validation throughout the lifecycle of software and automated systems.

The following actions outline a comprehensive model verification and validation strategy:

• Define Acceptance Criteria: Before commencing model validation, acceptance criteria should be established to determine the minimum performance levels acceptable for both verification and validation stages.
• Perform Verification: Systematically check that the AI/ML model functions as intended. This includes validating the underlying algorithms and assessing whether they adhere to designed specifications.
• Conduct Validation: Evaluate the model’s performance in real-world scenarios to confirm that it produces intended outcomes consistently and reliably.
• Documentation: All findings from verification and validation processes must be meticulously recorded to create a solid audit trail, which is crucial during regulatory inspections.

Additionally, manufacturers should align their V&V processes with relevant regulatory frameworks and international standards to maintain compliance and assurance in AI governance.

Step 4: Explainability and Transparency in AI Models

As AI systems become increasingly complex, understanding their decision-making processes becomes paramount. Explainability (XAI) is a measure that seeks to make AI/ML models transparent and interpretable. This is not only relevant from a regulatory perspective but also crucial for maintaining FDA and EMA guidelines on patient safety and product efficacy.

Implementing explainability involves:

• Model Interpretability: Choose models that naturally lend themselves to being interpreted or employ techniques that help clarify decision processes.
• Visualization Tools: Incorporate tools that help visualize model predictions and their influences. Visual explanations enhance stakeholder understanding and trust.
• User Training: Provide training for stakeholders who will interact with AI systems so they understand the underlying logic and can make better-informed decisions.
• Regular Updates: Continuously work on improving model explainability as part of the model management strategy, ensuring that all stakeholders remain informed.

Step 5: Drift Monitoring and Re-Validation

AI/ML models are not static; they may become less effective over time due to changes in data trends or concept drift. Drift monitoring and re-validation are crucial practices in maintaining AI/ML model efficacy during its operational lifecycle.

To effectively perform drift monitoring and facilitate re-validation, consider the following approaches:

• Establish Baseline Performance: Define baseline performance metrics at launch to facilitate comparison over time.
• Continuous Monitoring: Implement systems that constantly track model performance and highlight any deviations from baseline standards.
• Periodic Re-Validation: Schedule re-validation activities when significant performance drops are detected or when the underlying data changes significantly.
• Feedback Loops: Integrate feedback systems that utilize new incoming data to adapt and enhance the model iteratively.

Drift monitoring should be part of a broader AI governance framework to maintain compliance with regulatory standards, including those specified by authorities like PIC/S and ICH.

Step 6: Documentation and Audit Trails

The importance of documentation and audit trails cannot be overstated in AI governance. Regulatory agencies demand robust, traceable records to ensure accountability and quality control within AI/ML systems.

This documentation should encompass:

• Model Development History: Document each stage of the model’s lifecycle, from initial development through to deployment.
• Validation and Verification Reports: Keep comprehensive records of V&V processes, including the methodologies employed and any changes made to the model.
• User Access Logs: Establish audit trails that record who accessed models and what modifications were made, important for compliance under regulations such as Annex 11.
• Training and Testing Data Documentation: Maintain clear records of datasets used for training and testing, as required by regulatory expectations for data integrity.

A meticulous focus on documentation not only aids in regulatory compliance but also fosters trust among stakeholders in the integrity and accountability of AI/ML systems.

Step 7: Establishing a Governance Framework for AI Security

Establishing a comprehensive AI governance and security framework is essential for protecting proprietary algorithms, ensuring data privacy, and adhering to legal requirements. This framework should incorporate the following key components:

• Role Definition: Clearly define roles and responsibilities for managing AI systems across various stakeholders, from data scientists to compliance officers.
• Security Policies: Implement security protocols to protect sensitive data and model integrity against unauthorized access and cyber threats.
• Compliance Monitoring: Regularly evaluate practices against established regulations (e.g., 21 CFR Part 11) to ensure continuous compliance.
• Risk Assessment Protocols: Conduct periodic risk assessments to identify potential vulnerabilities in AI systems and implement appropriate mitigation strategies.

By adopting a governance framework that emphasizes security, pharmaceutical professionals can build trust in AI applications and assure compliance with both domestic and international regulatory standards.

Conclusion

In conclusion, the development and deployment of AI/ML models in pharmaceutical settings arise with considerable challenges that necessitate a solid framework for governance and security. Through the aforementioned steps, including comprehensive risk assessment, bias testing, model verification and validation, transparency, drift monitoring, constructive documentation, and a robust governance structure, pharmaceutical professionals can ensure their AI initiatives are not only compliant with regulatory standards but also effective in promoting patient safety and operational excellence.

The integration of AI/ML in GxP analytics is both inevitable and beneficial; thus, organizations must proactively embrace established best practices to secure a competitive edge in the pharmaceutical landscape.